In September 2022, life sciences publication PharmaVoice announced its top picks for its annual PharmaVoice 100 and Red Jacket Awards. The PharmaVoice 100 Award celebrates the most inspiring and influential thought leaders in the life sciences industry, and the Red Jacket Award honors those PharmaVoice 100 winners who consistently have raised the bar in an industry.
The editors at PharmVoice go through a thorough process of selecting candidates for both honors. Candidates chosen for the honor usually have a track record of success for their companies and patients. These people have facilitated industry change and positively impacted everyone around them. They also excel at being aware of trends in the industry, whether it is diversity, equity & inclusion, patient-centered product development, or other areas. In the past, for instance, candidates for the PharmaVoice 100 have been involved in initiatives that make health equity a priority daily, as is the case with Dr. Mary-Ann Etiebet, associate vice president of Merck and 2022 PharmaVoice 100 honoree. PharmaVoice 100 honorees are also innovators. They do more than stay ahead of trends. They also create innovation within the industry that culminates in new products, services, or strategies for approaching the various issues in life sciences. Moreover, their quick thinking helps them stay ahead of changes in the market. For example, one past honoree, Armon Sharei, received recognition for creating new ways to deploy cell therapies beginning with a basic premise he discovered while attending MIT. Beyond innovation, PharmaVoice 100 honorees can see into the future. As visionaries, these life sciences professionals are also entrepreneurs who look at past and present inventions to shape the life science industry far in the future. Further, they are not afraid of risk or being disruptors, and their progressive thinking culminates in transformative changes in the industry. Fahti Khosrowshahi, the founder of Ceek Women’s Health, made the 2022 PharmaVoice 100 list for introducing game-changing speculums (used for gynecological exams). PharmaVoice 100 honorees also pay it forward. The editors at the publication look at what candidates do with their opportunities to give back to society, whether through patient advocacy, philanthropy, community engagement, or mentorship. One past nominee and winner of the Red Jacket Award, Al Altomari, won because he advocated for women in leadership roles while also developing success in others as CEO of Agile Therapeutics. Then, some factors make a candidate attractive that do not fall into any one of these categories. Compelling personal narratives, breaking down barriers, or exciting work experiences or connections are all additional factors that make PharmaVoice 100 candidates attractive picks for the distinction. According to a March 2023 PharmaVoice article, these candidates possess the X factor, which does not fit in any category but has set them apart from the pack. In 2022, Roz Brewer, CEO of Walgreens Boots Alliance and a 2022 honoree used clinical trials to expand the company’s influence. Further, Bayer Pharmaceuticals president, Sebastian Guth, was honored in 2022 for advancing women in leadership at Bayer, improving access to treatments, community involvement, and facilitating a positive work culture. Finally, the Red Jacket Awards gives honorees extra kudos for appearing on the list multiple times or for exceeding in creating transformative change in an industry. Not only do they make a change, but they also build the platform for which others behind them can be changemakers.
0 Comments
|
AuthorKunal Ghosh - CEO of Inscopix ArchivesCategories |